Altamira Therapeutics Ltd Files For Offering 3.2M Of Common Shares On A Firm Commitment Basis; Final Public Offering Price Will Be Determined Through Negotiation Between Co And Representative Of Underwriters
Altamira Therapeutics Ltd Files For Offering 3.2M Of Common Shares On A Firm Commitment Basis; Final Public Offering Price Will Be Determined Through Negotiation Between Co And Representative Of Underwriters
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.